According to the IMARC Group, the 7 major Netherton syndrome markets reached a value of USD 21.4 Million in 2023. Looking ...

Intravenous immunoglobulin is used to treat many medical conditions, from chronic to acutely life-threatening, and its supply recently shifted abruptly and indefinitely, says Dr. Paul Biddinger ...

Researchers ask physicians to consider anti-IgLON5 disease if certain symptoms are present, as the only promising approach is ...

The increasing geriatric population favors the growth of the US intravenous immunoglobulin market. Immunoglobulins are the antibodies produced naturally by the body’s immune system, which help ...

According to Market.us, the market size for Intravenous Immunoglobulin was valued at USD 13.6 billion in 2022. It is projected to expand to approximately USD 24.4 billion by 2032. During the period ...

The Intravenous Immunoglobulin market was valued at US$ 11,206.54 million in 2021 and is expected to reach value of US$ 18,672.55 million by 2028; it is estimated to grow at a CAGR of 7.6% from ...

A national shortage of some brands of Intravenous Immunoglobulin, a life-improving and sometimes life-saving treatment of antibodies, is impacting patients in places from Boston to Virginia.

Intravenous Immunoglobulin IgG Response Associated with Poor Outcome in Guillain-Barré Syndrome - Medscape - Dec 15, 2009. References Authors and Disclosures Authors and Disclosures Author (s) ...